About: http://data.cimple.eu/news-article/f8bdee152e40ae113c3fa82e47a81c4bdf5b39b7839d836c55e220ea

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/f8bdee152e40ae113c3fa82e47a81c4bdf5b39b7839d836c55e220ea Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	A person who has previously had Covid and receives a single dose of either the Pfizer or Moderna vaccines is equally or better protected than someone who never had Covid and got two doses, according to a study. The paper was published in the New England Journal of Medicine on Wednesday and led by scientists at the Icahn School of Medicine at Mount Sinai in New York. The team looked at blood samples from 110 people, 67 of whom had not previously been infected and 43 who had. All participants received either the Pfizer or Moderna vaccines, which are based on new RNA (ribonucleic acid) technology. They found that participants who had been infected with the coronavirus before they received their first shot "rapidly developed uniform, high antibody titers within days after vaccination." "Titer" refers to blood concentration. The scientists repeatedly sampled the participants and found that in the days following the first shot, antibody levels in those with previous infection were 10 to 45 times higher than those who weren't previously infected. By the time both groups received their second shots, antibody levels among those previously infected still registered six times higher than those who weren't previously infected. But "no increase in antibody titers was observed in the Covid-19 survivors who received the second vaccine dose," the scientists wrote, indicating the booster was of limited benefit for people previously infected. No substantial difference in antibody production was noticed between the two vaccines. The team also looked at whether side effects differed in people with previous infection versus those without, studying 230 participants. Overall, there were no serious side effects that led to hospitalization. Vaccine recipients with preexisting immunity were found to have a higher frequency of mild to moderate side effects like fatigue, headache, chills, muscle pain, fever, and joint pain. But the team cautioned that limited data was available and more research was needed to confirm the trend. ia/ec
schema:headline	High protection after one vaccine dose for Covid survivors: study
schema:mentions	RNA virus Myalgia The Scientists Arthralgia Fatigue Headache New England Fever Antibody Ia (cuneiform) Immune system New York City Pfizer Coronavirus disease Vaccine Coronavirus Coronavirus disease 2019 Titer Mount Sinai Health System EC (programming language)
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2021-03-11 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	positive sentiment
http://data.cimple...readability_score	77 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 11 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software